Gilead Wants Whistleblowers' Drug Rx Kickback Suit Killed

Law360 (June 15, 2021, 7:59 PM EDT) -- Gilead Sciences Inc. argued on Monday that two ex-employees had no hard proof to back up claims that the company used sham speakership and advisory programs to pay illegal kickbacks to doctors who wrote a high volume of prescriptions for its hepatitis B drugs.

In a motion for summary judgment filed in federal court in Philadelphia, the company said one-time regional sales directors Chris Purcell and Kimberly Groome had failed to come up with any evidence that Gilead had illegally attempted to induce doctors it tapped for its so-called opinion leader programs to boost prescriptions for Viread and Vemlidy.

"After more...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!